Skip to Main content Skip to Navigation
Journal articles

Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation

Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-02153833
Contributor : Sandy Mzembaba <>
Submitted on : Wednesday, June 12, 2019 - 3:20:41 PM
Last modification on : Friday, April 24, 2020 - 2:22:02 PM

Identifiers

Collections

Citation

B. Delapierre, O. Reman, J. Dina, C. Breuil, M. Bellal, et al.. Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation. Current Research in Translational Medicine, Elsevier-Masson SAS, 2019, ⟨10.1016/j.retram.2019.03.001⟩. ⟨hal-02153833⟩

Share

Metrics

Record views

80